Salient Pharma ApS

  • Active

  • Registration 36900709
  • APS
  • Established 21 May, 2015

Company information
No advertising

Legal form
Anpartsselskab (APS)
Status

Active

 Established 21 May, 2015
Address
Naverland 22
C/O Biofarma Logistik
2600 Glostrup
Denmark
Phone: 42806300
Registration number
Registration 36900709

Relations

Past relations
Ultimate beneficial owners (UBOs)
  • Ulrik Spork
    2015-05-21 – 28.9% ownership (2015-05-21 – 2023-12-30 ) 32.8% ownership (2023-12-31 – 2024-06-27 ) 33.8% ownership (2024-06-28 – ) 28.9% voting rights (2015-05-21 – 2023-12-30 ) 32.8% voting rights (2023-12-31 – 2024-06-27 ) 33.8% voting rights (2024-06-28 – )
  • Helle Bøwadt
    2016-02-22 – 40.4% ownership (2016-02-22 – 2023-12-30 ) 45.8% ownership (2023-12-31 – 2024-06-27 ) 47.2% ownership (2024-06-28 – ) 40.4% voting rights (2016-02-22 – 2023-12-30 ) 45.8% voting rights (2023-12-31 – 2024-06-27 ) 47.2% voting rights (2024-06-28 – )
  • Søren Johannes Kjær Henningsen
    2016-02-22 – 2024-06-28 2.55% ownership (2023-12-31 – 2024-06-28 ) 8.15% ownership (2016-02-22 – 2023-12-30 ) 2.55% voting rights (2023-12-31 – 2024-06-28 ) 8.15% voting rights (2016-02-22 – 2023-12-30 )
  • Susanne Kjær Henningsen
    2016-02-22 – 2024-06-28 2.55% ownership (2023-12-31 – 2024-06-28 ) 8.15% ownership (2016-02-22 – 2023-12-30 ) 2.55% voting rights (2023-12-31 – 2024-06-28 ) 8.15% voting rights (2016-02-22 – 2023-12-30 )
Legal owners
  • HB-MEDICAL HOLDING ApS 50% ownership (2016-02-22 – 2016-08-30 ) 33.33% ownership (2016-08-31 – ) 50% voting rights (2016-02-22 – 2016-08-30 ) 33.33% voting rights (2016-08-31 – )
  • SPORCON LIFESCIENCE ADVISORS ApS 100% ownership (2015-05-21 – 2016-02-21 ) 25% ownership (2016-02-22 – ) 100% voting rights (2015-05-21 – 2016-02-21 ) 25% voting rights (2016-02-22 – )
  • Kjær Henningsen Holding ApS 15% ownership (2016-02-22 – 2016-08-30 ) 10% ownership (2016-08-31 – 2018-10-21 ) 5% ownership (2018-10-22 – 2024-06-28 ) 15% voting rights (2016-02-22 – 2016-08-30 ) 10% voting rights (2016-08-31 – 2018-10-21 ) 5% voting rights (2018-10-22 – 2024-06-28 )
  • CAND.PHARM. POVL M. ASSENS FOND 15% ownership (2018-08-31 – 2018-10-21 ) 10% ownership (2018-10-22 – 2023-12-30 ) 15% voting rights (2018-08-31 – 2018-10-21 ) 10% voting rights (2018-10-22 – 2023-12-30 )
  • Kjær Henningsen Holding ApS 15% ownership (2016-02-22 – 2016-08-30 ) 10% ownership (2016-08-31 – 2018-10-21 ) 5% ownership (2018-10-22 – 2024-06-28 ) 15% voting rights (2016-02-22 – 2016-08-30 ) 10% voting rights (2016-08-31 – 2018-10-21 ) 5% voting rights (2018-10-22 – 2024-06-28 )
  • CAND.PHARM. POVL M. ASSENS FOND 15% ownership (2018-08-31 – 2018-10-21 ) 10% ownership (2018-10-22 – 2023-12-30 ) 15% voting rights (2018-08-31 – 2018-10-21 ) 10% voting rights (2018-10-22 – 2023-12-30 )
  • HB-MEDICAL HOLDING ApS 50% ownership (2016-02-22 – 2016-08-30 ) 33.33% ownership (2016-08-31 – ) 50% voting rights (2016-02-22 – 2016-08-30 ) 33.33% voting rights (2016-08-31 – )
  • Kjær Henningsen Holding ApS 15% ownership (2016-02-22 – 2016-08-30 ) 10% ownership (2016-08-31 – 2018-10-21 ) 5% ownership (2018-10-22 – 2024-06-28 ) 15% voting rights (2016-02-22 – 2016-08-30 ) 10% voting rights (2016-08-31 – 2018-10-21 ) 5% voting rights (2018-10-22 – 2024-06-28 )
  • SPORCON LIFESCIENCE ADVISORS ApS 100% ownership (2015-05-21 – 2016-02-21 ) 25% ownership (2016-02-22 – ) 100% voting rights (2015-05-21 – 2016-02-21 ) 25% voting rights (2016-02-22 – )
Directors
Board members

Employees

Salient Pharma ApS has 1.00 full time equivalents (FTEs) and 1.00 employees as of 1 June, 2020.